| Product Code: ETC7648017 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Industry Life Cycle |
3.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Porter's Five Forces |
3.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By ACE Inhibitors, 2021 & 2031F |
3.7 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease (CKD) in Israel |
4.2.2 Growing awareness and diagnosis of mineral bone disorders (MBD) in CKD patients |
4.2.3 Technological advancements in treatment options for CKD-MBD |
4.3 Market Restraints |
4.3.1 High cost associated with CKD-MBD treatment |
4.3.2 Limited healthcare infrastructure and resources in Israel for CKD patients |
4.3.3 Stringent regulatory requirements for approval of CKD-MBD treatment options |
5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Trends |
6 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Types |
6.1 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Medications And Supplements, 2021- 2031F |
6.1.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Dialysis, 2021- 2031F |
6.1.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Surgery, 2021- 2031F |
6.1.6 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Diet, 2021- 2031F |
6.1.7 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.8 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By ACE Inhibitors |
6.2.1 Overview and Analysis |
6.2.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By B-blockers, 2021- 2031F |
6.2.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Calcium Channel Blockers, 2021- 2031F |
6.2.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Loop Diuretics, 2021- 2031F |
6.2.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Erythropoiesis-Stimulating Agents (ESAs), 2021- 2031F |
6.2.6 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Phosphate Binders, 2021- 2031F |
6.2.7 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.3.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Ambulatory Surgical Centres, 2021- 2031F |
6.4.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Import-Export Trade Statistics |
7.1 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Export to Major Countries |
7.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Imports from Major Countries |
8 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Key Performance Indicators |
8.1 Number of CKD patients diagnosed with mineral bone disorders annually in Israel |
8.2 Adoption rate of innovative treatment options for CKD-MBD in Israel |
8.3 Average time from diagnosis to initiation of treatment for CKD-MBD in Israel |
9 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Opportunity Assessment |
9.1 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By ACE Inhibitors, 2021 & 2031F |
9.3 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market - Competitive Landscape |
10.1 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Chronic Kidney Disease - Mineral Bone Disorders (CKD-MBD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here